Page 270 - 18F-FDG PET as biomarker in aggressive lymphoma; technical and clinical validation

Addendum
List of Abbreviations
[18F]-FDG 95% CI aaIPI
ABC ABVD ASCT AVD
AUC BEACOPP
BEAM CAR-T CD CHOP CMR CNS CR
CT
CoV
DFS DICOM DLBCL DS EANM EFS EoT-PET FISH FFS
FL
GCB HL HOVON HR HSROC
18F-fluoro-2-deoxy-D-glucose
95% confidence interval
age-adjusted international prognostic index
activated B-cell
doxorubicin, bleomycin, vincristine, dacarbazine autologous stem cell transplantation
doxorubicin, vincristine, dacarbazine
area under the curve
bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone
carmustine, etoposide, cytarabin, melphalan
chimeric antigen receptor T-cells
cluster of differentiation
cyclophosphamide, doxorubicin, vincristine, prednisone complete metabolic response
central nervous system
complete remission
computed tomography
coefficient of variation
disease-free survival
digital imaging and communications in medicine
diffuse large B-cell lymphoma
Deauville 5-point scale
European Association of Nuclear Medicine
event-free survival
end-of-treatment positron emission tomography fluorescent in situ hybridization
failure-free survival
follicular lymphoma
germinal center B-cell
Hodgkin lymphoma
stichting Hemato-Oncologie voor Volwassenen Nederland hazard ratio
hierarchical summary ROC curve
268